5-Methoxy-N,N-diisopropyltryptamine

5-Methoxy-"N","N"-diisopropyltryptamine (5-MeO-DiPT, sometimes called Foxy Methoxy) is a psychedelic tryptamine and the methoxy derivative of diisopropyltryptamine (DiPT).
Pharmacology.
The mechanism that produces the purported hallucinogenic and entheogenic effects of 5-MeO-DiPT is thought to result primarily from 5-HT2A receptor agonism, although additional mechanisms of action such as monoamine oxidase inhibition (MAOI) may be involved also. The strongest receptor binding affinity for 5-MeO-DiPT is at the 5-HT1A receptor.
5-MeO-DiPT is neurotoxic in rats.
Overdose.
Excessive doses have caused clinical intoxication, characterized by nausea, vomiting, agitation, hypotension, mydriasis, tachycardia and hallucinations, in a number of young adults. A number of these overdoses are attributed to the drug’s extended onset of action, where first time users, who were unfamiliar with the drug, administered a second dose after initially feeling no effects. Rhabdomyolysis and renal failure occurred in one young man and another one died 3–4 hours after an apparent rectal overdose. At least one death has been attributed to consumption of 5-MeO-DiPT.
Drug prohibition laws.
China.
As of October 2015 5-MeO-DiPT is a controlled substance in China.
Denmark.
Illegal since February 2004.
Germany.
Illegal since September 1999.
Greece.
Illegal since February 2003.
Japan.
Illegal since April 2005.
Singapore.
Illegal since early 2006.
Sweden.
"Sveriges riksdags" health ministry classified 5-MeO-DiPT as "health hazard" under the act (translated "Act on the Prohibition of Certain Goods Dangerous to Health") as of Oct 1, 2004, in their regulation SFS 2004:696 listed as 5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT), making it illegal to sell or possess.
United States.
On April 4, 2003, the United States DEA added both 5-MeO-DiPT and alpha-methyltryptamine (AMT) to Schedule I of the Controlled Substances Act under "emergency scheduling" procedures. The drugs were officially placed into Schedule I on September 29, 2004. Prior to its prohibition in the U.S., 5-MeO-DiPT was sold online alongside psychoactive analogues such as DiPT, and DPT, neither of which have yet been expressly outlawed.